Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancers.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.3076
Abstract: 3076Background: In advanced cancer, the overall response rate (ORR) following anti-PD1 monotherapy is variable (0% to 50%). Here, we hypothesized that this observation is partly explained by differ... read more here.
Keywords: pd1 monotherapy; anti pd1; response; association pd1 ... See more keywords